Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence

Family Practice

Volumn 28, Issue 5, 2011, Pages 524-531

  Vashitz, Geva ^a   Meyer, Joachim ^a   Parmet, Yisrael ^a   Henkin, Yaakov ^a,b   Peleg, Roni ^a,c   Gilutz, Harel ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

Author keywords

Adherence; Cholesterol; Compliance; Coronary heart disease; Evidence based medicine; Guideline; Primary care

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; DYSLIPIDEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PHYSICIAN ADHERENCE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; SECONDARY PREVENTION;

AGED; ANTICHOLESTEREMIC AGENTS; DYSLIPIDEMIAS; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPOLIPIDEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; SECONDARY PREVENTION;

EID: 80052917027     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmr025     Document Type: Article

References (34)

1. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics-2009 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2009; 119: e21-181.
2. Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American college of Cardiology/American heart association task force on practice guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: E1-211.
3. Wood D, De Backer G, Faergeman O et al. Prevention of coronary heart disease in clinical practice: recommendations of the second joint task force of European and other societies on coronary prevention. Atherosclerosis 1998; 140: 199-270.
4. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143-421.
5. Nissen SE, Tuzcu EM, Schoenhagen P et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352: 29-38.
6. Newby LK, LaPointe NM, Chen AY et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006; 113: 203-12.
7. Yan AT, Yan RT, TanMet al. Contemporary management of dyslipidemia in high-risk patients: targets still not met. Am J Med 2006; 119: 676-83.
8. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
9. Lewis WR, Peterson ED, Cannon CP et al. An organized approach to improvement in guideline adherence for acute myocardial infarction: results with the get with the guidelines quality improvement program. Arch Intern Med 2008; 168: 1813-9.
10. Powell-Cope GM, Luther S, Neugaard B et al. Provider-perceived barriers and facilitators for ischaemic heart disease (IHD) guideline adherence. J Eval Clin Pract 2004; 10: 227-39.
11. Mosca L, Linfante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499-510.
12. Christensen AJ, Howren MB, Hillis SL et al. Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence. J Gen Intern Med 2010; 25: 397-402.
13. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2010; 3: CD004371.
14. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462-7.
15. Gilutz H, Novack L, Shvartzman P et al. Computerized community cholesterol control (4C): meeting the challenge of secondary prevention. Isr Med Assoc J 2009; 11: 23-9.
16. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
17. McCulloch CE, Searle SR. Generalized, Linear, and Mixed Models. New York: John Wiley, 2001, pp. 208-12.
18. Calvert MJ, Shankar A, McManus RJ et al. Evaluation of the management of heart failure in primary care. Fam Pract 2009; 26: 145-53.
19. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002; 19: 596-604.
20. Ab E, Denig P, van Vliet T et al. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study. BMC Fam Pract 2009; 10: 24.
21. Krahn M, Naglie G. The next step in guideline development: incorporating patient preferences. JAMA 2008; 300: 436-8.
22. Benner JS, Tierce JC, Ballantyne CM et al. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoeconomics 2004; 22: 13-23.
23. Vashitz G, Meyer J, Parmet Y et al. Defining and measuring physicians' responses to clinical reminders. J Biomed Inform 2009; 42: 317-26.
24. Benner JS, Glynn RJ, Mogun H et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288: 455-61.
25. Chan DC, Shrank WH, Cutler D et al. Patient, physician, and payment predictors of statin adherence. Med Care 2010; 48: 196-202.
26. Baumhakel M, Muller U, Bohm M. Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 2009; 11: 299-303.
27. Roter DL, Hall JA, Aoki Y. Physician gender effects in medical communication: a meta-analytic review. JAMA 2002; 288: 756-64.
28. Schmittdiel JA, Uratsu CS, Karter AJ et al. Why don't diabetes patients achieve recommended risk factor targets? Pooradherence versus lack of treatment intensification. J Gen Intern Med 2008; 23: 588-94.
29. Fharm E, Rolandsson O, Johansson EE. 'Aiming for the stars'-GPs' dilemmas in the prevention of cardiovascular disease in type 2 diabetes patients: focus group interviews. Fam Pract 2009; 26: 109-14.
30. Safford MM, Shewchuk R, Qu H et al. Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care. J Gen Intern Med 2007; 22: 1648-55.
31. Campione JR, Sleath B, Biddle AK et al. The influence of physicians' guideline compliance on patients' statin adherence: a retrospective cohort study. Am J Geriatr Pharmacother 2005; 3: 229-39.
32. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-67.
33. Gavish D, Leibovitz E, Elly I et al. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients. Isr Med Assoc J 2002; 4: 694-7.
34. Gersh BJ, Sliwa K, Mayosi BM et al. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 2010; 31: 642-8.